Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Plasma cell 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Melanoma 5Lung Neoplasms 3Urinary Bladder Neoplasms 2Small Cell Lung Carcinoma 2Ovarian Neoplasms 2Esophageal Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Sarcoma 1Neoplasms, Squamous Cell 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Mesothelioma 1Chondrosarcoma 1Carcinoma, Transitional Cell 1Carcinoma, Merkel Cell 1Carcinoma, Hepatocellular 1Adenocarcinoma 1

Interventions

belinostat 2Filgrastim 2Docetaxel 2tazemetostat 1resiquimod 1poly ICLC 1etoposide phosphate 1alanosine 1Thalidomide 1Quality of Life 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Immunotherapy 1Immunologic Techniques 1Imatinib Mesylate 1Ifosfamide 1Gemcitabine 1Fluorouracil 1Fentanyl 1Etoposide 1Drug Therapy 1Cyclophosphamide 1Cryosurgery 1Carboplatin 1Biological Therapy 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma × poly ICLC × Thoracic × Clear all
NCT00948961 2016-06-27

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Celldex Therapeutics

Phase 1/2 Completed
70 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicPlasma cellSarcomaThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Esophageal Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡